tiprankstipranks
Tempest receives FDA study may proceed for Phase 3 trial of amezalpat
PremiumThe FlyTempest receives FDA study may proceed for Phase 3 trial of amezalpat
2M ago
Tempest Therpeutics options imply 22.5% move in share price post-earnings
Premium
The Fly
Tempest Therpeutics options imply 22.5% move in share price post-earnings
2M ago
Tempest Therapeutics, Inc. (TPST) Q3 Earnings Cheat Sheet
Premium
Pre-Earnings
Tempest Therapeutics, Inc. (TPST) Q3 Earnings Cheat Sheet
2M ago
Tempest Therapeutics appoints Troy Wagner as VP, quality assurance
PremiumThe FlyTempest Therapeutics appoints Troy Wagner as VP, quality assurance
5M ago
Tempest announces feedback form End-of-Phase 2 meeting with FDA for TPST-1120
Premium
The Fly
Tempest announces feedback form End-of-Phase 2 meeting with FDA for TPST-1120
5M ago
TPST Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
TPST Upcoming Earnings Report: What to Expect?
5M ago
Is TPST a Buy, Before Earnings?
PremiumPre-EarningsIs TPST a Buy, Before Earnings?
8M ago
Largest borrow rate increases among liquid names
Premium
The Fly
Largest borrow rate increases among liquid names
9M ago
Tempest presents data showing PST-1120 reduces RCC growth as a monotherapy
Premium
The Fly
Tempest presents data showing PST-1120 reduces RCC growth as a monotherapy
9M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100